NEWS

Neuren drug finally been cleared by FDA in USA

SYDNEY: Australia’s top performing health stock for 2022, Neuren, has gained clearance from the US… read more

Mesoblast shares surge on FDA filing in USA

SYDNEY: Mesoblast chief executive Silviu Itescu says a more than 12 per cent jump is… read more

12 new senior healthcare executives sought for key roles

MELBOURNE: Twelve senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more

MBK now set to buy Japan aged care business

TOKYO: MBK Partners has acquired Unimat Retirement Community (URC), a Japan-based company that primarily provides… read more